DOW JONES22,091.21+454.43 2.10%
S&P 5002,603.89+62.42 2.46%
NASDAQ7,718.38+216.00 2.88%

Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $12

Wells Fargo analyst Jacob Hughes maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $10 to $12.

Benzinga · 03/05/2020 14:23

Wells Fargo analyst Jacob Hughes maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $10 to $12.